Han SN, Oza A, Colombo N, Oaknin A, et al. A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer. Gynecol Oncol 2023;178:110-118.
PMID: 37839313